Iovance Biotherapeutics, Inc. (IOVA)
4.00
-0.23
(-5.44%)
USD |
NASDAQ |
Jun 08, 16:00
4.00
0.00 (0.00%)
After-Hours: 18:30
Iovance Biotherapeutics Shareholders Equity (Quarterly) : 721.75M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -221.22M |
| Neurocrine Biosciences, Inc. | 3.407B |
| Amgen, Inc. | 9.19B |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| Imunon, Inc. | 3.360M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 925.66M |
| Total Liabilities (Quarterly) | 203.91M |
| Debt to Equity Ratio | 0.0662 |
| Current Ratio | 3.605 |
| Net Debt Paydown Yield | 0.14% |